Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.70
+0.03 (0.39%)
Apr 29, 2026, 9:30 AM EDT - Market open
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $703.12 million as of April 29, 2026. Its market cap has increased by 3.03% in one year.
Market Cap
703.12M
Enterprise Value
648.89M
1-Year Change
3.03%
Ranking
Category
Stock Price
$7.70
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $703.12M, an increase of 36.42%. That is a compound annual growth rate of 13.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 696.73M | 8.58% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 762.29M |
| Relmada Therapeutics | 759.39M |
| Absci | 755.47M |
| Allogene Therapeutics | 753.31M |
| Solid Biosciences | 733.04M |
| BridgeBio Oncology Therapeutics | 704.29M |
| Lexicon Pharmaceuticals | 703.31M |
| First Tracks Biotherapeutics | 696.71M |